✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹4,284 Cr.
P/E
31.15
  • Unichem Lab
  • Sequent Scientific
  • Guj. Themis Biosyn
  • TJI Pharma - Small Cap
FAQs on Unichem Laboratories Ltd. Shareprice

Unichem Lab has given lower returns compared to its competitors.
Unichem Lab has grown at ~10.74% over the last 8yrs while peers have grown at a median rate of 23.22%

Unichem Lab is not expensive.
Latest PE of Unichem Lab is 31.15, while 3 year average PE is 42.11.
Also latest EV/EBITDA of Unichem Lab is 17.01 while 3yr average is 82.85.

Growth Table
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Balance Sheet
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Cash Flow
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Quarterly Results
  • Unichem Laboratories Ltd.
  • Sequent Scientific
  • Guj. Themis Biosyn
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Unichem Laboratories Ltd. Financials

Balance sheet of Unichem Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Unichem Lab is increasing.
Latest net debt of Unichem Lab is ₹195 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹97.12 Crs.

Yes, profit is increasing.
The profit of Unichem Lab is ₹138 Crs for Mar 2025, -₹93.76 Crs for Mar 2024 and -₹202.23 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Unichem Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech